Separate Non-Financial Group Report

Overview

The report presents Dermapharm's first Group-wide GHG inventory under the Greenhouse Gas Protocol, with 2025 gross Scope 1 of 13,310 t CO2e, location-based Scope 2 of 9,647 t CO2e, and Scope 3 of 267,594 t CO2e. Total energy consumption was 110,705 MWh, with renewable sources at 26%, while waste generated was 8,716 tonnes. The report applies a double materiality assessment across the consolidated group and reports 3,454 year-end employees. It also describes Group-wide ESG governance and discloses no confirmed corruption or bribery cases in 2025.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 31 March 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services